The world's No. 2 software maker announced on Apr. 16 that it is buying Phase Forward (PFWD) for about $685 million. The Waltham (Mass.) company markets software that helps drug companies conduct clinical trials. Oracle (ORCL) CEO Larry Ellison has spent some $42 billion over the past five years on acquisitions aimed at boosting the company's profile in industries such as retail, telecom, and now health care.
Before it's here, it's on the Bloomberg Terminal. LEARN MORE